Synedrex is a high quality performance fat burner that contains potent thermogenic ingredients to get you shredded. Synedrex contains the world's first 4 step metabolic accelerator. Synedrex works by addressing the 4 problem areas which can slow your metabolic rate. Synedrex is a research-designed gel-cap that stimulates metabolic receptors to burn calories faster. Synedrex begins to work instantly to increase your metabolic rate. Since metabolism varies from person to person, fat loss results will vary.
Metabolic Nutrition recommends that you only take 1 capsule per 24 hours. Due to the strength and potency of Synedrex it is highly recommended that for the first few days take with food. Then once tolerance is accessed, take in the morning on an empty stomch. Do not exceed more than 1 capsule per day or 12 hours before bedtime!
Not intended for use by persons under 18. Do not exceed recommended dosage per day, doing so will not improve results and will result in adverse health effects. Not to be used by pregnant or nursing women or person(s) who have a pre-existing health condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart/kidney/liver/thyroid disease, seizure disorder, psychiatric issues, diabetes, stimulant sensitivity or allergies, prostate inflammation, or while taking any other medication (such as, but not limited to: MAO-inhibitor or SSRI’s). DO NOT use in combination with other stimulant products or alcohol. If you experience rapid heartbeat, dizziness, severe headache, shortness of breath, or similar symptoms; discontinue use immediately and call a health care professional. DO NOT use SYNEDREX longer than 60 days continuously. Contains caffeine. KEEP OUT OF REACH OF CHILDREN.
Trexler ET, Roelofs EJ, Hirsch KR, Mock MG, Smith-Ryan AE. Effects of coffee and caffeine anhydrous on strength and sprint performance. J Int Soc Sports Nutr. 2015;12(Suppl 1):P57. Published 2015 Sep 21. doi:10.1186/1550-2783-12-S1-P57
Ilic N, Schmidt BM, Poulev A, Raskin I. Toxicological evaluation of grains of paradise (Aframomum melegueta) [Roscoe] K. Schum. J Ethnopharmacol. 2010;127(2):352–356. doi:10.1016/j.jep.2009.10.031